A research project funded by equine charity The Horse Trust has succeeded in killing equine sarcoid cells in vitro by silencing a gene in the virus that causes sarcoids. The researchers are now hoping to obtain funding for clinical trials using the new…

The Royal Veterinary College has announced that work it conducted with King’s College London (KCL), the University of Edinburgh and University College London (UCL), has led to a breakthrough in the understanding of squamous cell carcinoma (SCC)¹.

Squamous…

Viennese biotech company BlueSky Immunotherapies says it has used its viral vector platform delNS to treat sarcoids in horses successfully, paving the way for a new cancer therapy in humans.

BlueSky says that conventional treatment for equine sarcoids…